FLGT
Price
$20.19
Change
+$0.49 (+2.49%)
Updated
May 12, 04:59 PM (EDT)
Capitalization
648.84M
81 days until earnings call
LAB
Price
$1.15
Change
+$0.08 (+7.48%)
Updated
May 12, 03:44 PM (EDT)
Capitalization
1.04B
86 days until earnings call
Ad is loading...

FLGT vs LAB

Header iconFLGT vs LAB Comparison
Open Charts FLGT vs LABBanner chart's image
Fulgent Genetics
Price$20.19
Change+$0.49 (+2.49%)
Volume$6.62K
Capitalization648.84M
Standard BioTools
Price$1.15
Change+$0.08 (+7.48%)
Volume$100
Capitalization1.04B
FLGT vs LAB Comparison Chart
Loading...
FLGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FLGT vs. LAB commentary
May 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FLGT is a Hold and LAB is a Buy.

Ad is loading...
COMPARISON
Comparison
May 12, 2025
Stock price -- (FLGT: $19.70 vs. LAB: $1.07)
Brand notoriety: FLGT and LAB are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: FLGT: 67% vs. LAB: 46%
Market capitalization -- FLGT: $648.84M vs. LAB: $1.04B
FLGT [@Medical Specialties] is valued at $648.84M. LAB’s [@Medical Specialties] market capitalization is $1.04B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FLGT’s FA Score shows that 1 FA rating(s) are green whileLAB’s FA Score has 1 green FA rating(s).

  • FLGT’s FA Score: 1 green, 4 red.
  • LAB’s FA Score: 1 green, 4 red.
According to our system of comparison, FLGT is a better buy in the long-term than LAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FLGT’s TA Score shows that 6 TA indicator(s) are bullish while LAB’s TA Score has 3 bullish TA indicator(s).

  • FLGT’s TA Score: 6 bullish, 3 bearish.
  • LAB’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, FLGT is a better buy in the short-term than LAB.

Price Growth

FLGT (@Medical Specialties) experienced а -4.09% price change this week, while LAB (@Medical Specialties) price change was -10.83% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.71%. For the same industry, the average monthly price growth was +6.61%, and the average quarterly price growth was -1.59%.

Reported Earning Dates

FLGT is expected to report earnings on Aug 01, 2025.

LAB is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Medical Specialties (+0.71% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LAB($1.04B) has a higher market cap than FLGT($649M). FLGT YTD gains are higher at: 6.659 vs. LAB (-38.857). FLGT has higher annual earnings (EBITDA): -49.15M vs. LAB (-54.46M). FLGT has more cash in the bank: 424M vs. LAB (115M). FLGT has less debt than LAB: FLGT (15.3M) vs LAB (98.2M). FLGT has higher revenues than LAB: FLGT (289M) vs LAB (106M).
FLGTLABFLGT / LAB
Capitalization649M1.04B63%
EBITDA-49.15M-54.46M90%
Gain YTD6.659-38.857-17%
P/E Ratio7.33N/A-
Revenue289M106M273%
Total Cash424M115M369%
Total Debt15.3M98.2M16%
FUNDAMENTALS RATINGS
FLGT vs LAB: Fundamental Ratings
FLGT
LAB
OUTLOOK RATING
1..100
5761
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
29
Undervalued
PROFIT vs RISK RATING
1..100
93100
SMR RATING
1..100
9093
PRICE GROWTH RATING
1..100
4489
P/E GROWTH RATING
1..100
6100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LAB's Valuation (29) in the Medical Specialties industry is in the same range as FLGT (53) in the Medical Or Nursing Services industry. This means that LAB’s stock grew similarly to FLGT’s over the last 12 months.

FLGT's Profit vs Risk Rating (93) in the Medical Or Nursing Services industry is in the same range as LAB (100) in the Medical Specialties industry. This means that FLGT’s stock grew similarly to LAB’s over the last 12 months.

FLGT's SMR Rating (90) in the Medical Or Nursing Services industry is in the same range as LAB (93) in the Medical Specialties industry. This means that FLGT’s stock grew similarly to LAB’s over the last 12 months.

FLGT's Price Growth Rating (44) in the Medical Or Nursing Services industry is somewhat better than the same rating for LAB (89) in the Medical Specialties industry. This means that FLGT’s stock grew somewhat faster than LAB’s over the last 12 months.

FLGT's P/E Growth Rating (6) in the Medical Or Nursing Services industry is significantly better than the same rating for LAB (100) in the Medical Specialties industry. This means that FLGT’s stock grew significantly faster than LAB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FLGTLAB
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
81%
Momentum
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
Bullish Trend 4 days ago
65%
Bearish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 19 days ago
76%
Bullish Trend 21 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 6 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
87%
Aroon
ODDS (%)
Bullish Trend 4 days ago
73%
N/A
View a ticker or compare two or three
Ad is loading...
FLGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGLMX16.210.08
+0.50%
MFS Global Real Estate R4
FSOSX15.290.05
+0.33%
Fidelity Series Overseas
JOMMX13.090.04
+0.31%
JOHCM Emerging Mkts Discovery Instl
DRSVX16.580.04
+0.24%
North Square Small Cap Value Investor
GITIX34.19-0.06
-0.18%
Goldman Sachs Technology Opps Inst